
According to Benzinga Pro, during Q4, Mednax (NYSE:MD) earned $47.51 million, a 54.31% increase from the preceding quarter. Mednax also posted a total of $498.53 million in sales, a 1.13% increase since Q3. In Q3, Mednax earned $30.79 million, and total sales reached $492.95 million.